Nan Fung Life Sciences
Mischa Travers is the US Chief Operating Officer and General Counsel of Pivotal Life Sciences. He joined Pivotal in 2022 and brings over 20 years’ experience in finance, legal, and operating roles across a range of organizations. Prior to Pivotal, he was Chief Financial Officer and General Counsel at Cequence Security, a venture-backed cybersecurity software company. Prior to that, Mr. Travers was a partner at Davis Polk & Wardwell where he advised technology and life sciences companies on mergers and acquisitions, securities offerings, corporate governance, strategic partnerships, and SEC reporting and compliance issues; a derivatives trader and merger arbitrageur at Cutler Group, LP; and an investment banker focusing on the software industry at Credit Suisse First Boston. Mr. Travers holds a J.D. degree from the University of Chicago Law School and a B.S. in Industrial and Systems Engineering from Virginia Tech.
Nan Fung Life Sciences
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations, and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices, and diagnostics) and across different development stages, Nan Fung Life Sciences has a significant presence in both US and Greater China.